Hunan Hansen Pharmaceutical Co Ltd Total Liabilities
Hunan Hansen Pharmaceutical Co Ltd total liabilities. Based on the latest financial reports, Hunan Hansen Pharmaceutical Co Ltd (002412) has total liabilities worth CN¥310.49 Million CNY (≈ $45.43 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Hunan Hansen Pharmaceutical Co Ltd (002412) asset resilience to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Hunan Hansen Pharmaceutical Co Ltd (2006–2025)
Total liabilities of Hunan Hansen Pharmaceutical Co Ltd from 2006 to 2025. This chart illustrates how Hunan Hansen Pharmaceutical Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore Hunan Hansen Pharmaceutical Co Ltd long-term investment intensity to see how much of total assets are deployed in long-term investments.
Hunan Hansen Pharmaceutical Co Ltd Competitors by Total Liabilities
The table below lists competitors of Hunan Hansen Pharmaceutical Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
G-Tech Optoelectronics Corp
TW:3149
|
Taiwan | NT$3.16 Billion |
|
Atlanta Braves Holdings, Inc. Series A Common Stock
NASDAQ:BATRA
|
USA | $1.21 Billion |
|
Saha Pathanapibul Public Company Limited
BK:SPC
|
Thailand | ฿9.69 Billion |
|
Merry Electronics Co Ltd
TW:2439
|
Taiwan | NT$22.64 Billion |
|
Shenzhen Kaizhong Precision Technology Co Ltd
SHE:002823
|
China | CN¥1.57 Billion |
|
BEIJ.JINGNENG CL.ERG.HYC1
F:BJ6
|
Germany | €64.73 Billion |
|
Shenzhen Liande Automatic Equipment Co Ltd
SHE:300545
|
China | CN¥806.34 Million |
|
Thai Stanley Electric Public Company Limited
BK:STANLY
|
Thailand | ฿2.52 Billion |
Liability Composition Analysis (2006–2025)
This chart breaks down Hunan Hansen Pharmaceutical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Hunan Hansen Pharmaceutical Co Ltd asset portfolio.
Liquidity & Leverage Metrics
Hunan Hansen Pharmaceutical Co Ltd Total Liabilities Ratios Explained
Hunan Hansen Pharmaceutical Co Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 4.80 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.13 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.11 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Hunan Hansen Pharmaceutical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Hunan Hansen Pharmaceutical Co Ltd (2006–2025)
The table below shows the annual total liabilities of Hunan Hansen Pharmaceutical Co Ltd from 2006 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥312.15 Million ≈ $45.68 Million |
-9.22% |
| 2024-12-31 | CN¥343.85 Million ≈ $50.32 Million |
-7.93% |
| 2023-12-31 | CN¥373.46 Million ≈ $54.65 Million |
-5.89% |
| 2022-12-31 | CN¥396.81 Million ≈ $58.07 Million |
+7.54% |
| 2021-12-31 | CN¥368.99 Million ≈ $53.99 Million |
+25.54% |
| 2020-12-31 | CN¥293.92 Million ≈ $43.01 Million |
-16.72% |
| 2019-12-31 | CN¥352.93 Million ≈ $51.64 Million |
-18.87% |
| 2018-12-31 | CN¥435.02 Million ≈ $63.66 Million |
-9.59% |
| 2017-12-31 | CN¥481.18 Million ≈ $70.41 Million |
+15.70% |
| 2016-12-31 | CN¥415.88 Million ≈ $60.86 Million |
+227.90% |
| 2015-12-31 | CN¥126.83 Million ≈ $18.56 Million |
-40.89% |
| 2014-12-31 | CN¥214.59 Million ≈ $31.40 Million |
+0.06% |
| 2013-12-31 | CN¥214.46 Million ≈ $31.38 Million |
+179.39% |
| 2012-12-31 | CN¥76.76 Million ≈ $11.23 Million |
+39.70% |
| 2011-12-31 | CN¥54.95 Million ≈ $8.04 Million |
+11.61% |
| 2010-12-31 | CN¥49.23 Million ≈ $7.20 Million |
-27.27% |
| 2009-12-31 | CN¥67.69 Million ≈ $9.90 Million |
-20.06% |
| 2008-12-31 | CN¥84.67 Million ≈ $12.39 Million |
-2.11% |
| 2007-12-31 | CN¥86.49 Million ≈ $12.66 Million |
-40.13% |
| 2006-12-31 | CN¥144.46 Million ≈ $21.14 Million |
-- |
About Hunan Hansen Pharmaceutical Co Ltd
Hunan Hansen Pharmaceutical Co., Ltd. engages in the production and sale of traditional Chinese preparations in China and internationally. The company offers medications for digestive, cardiovascular, cerebrovascular, and urological diseases, as well as for traumatology and diagnostic applications. It provides its products in various forms, including injections, mixtures, tablets, capsules, granu… Read more